The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.50
Bid: 48.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.083%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Cognition shares surge as it eyes profitability in 2021

Tue, 23rd Mar 2021 11:58

(Alliance News) - Cambridge Cognition Holdings PLC on Tuesday reported a strong rise in annual revenue amid record sales order intake, as the software company eyes a swing to annual profit in 2021.

Cambridge Cognition shares soared 13% at 85.00 pence each in London on Tuesday morning.

Cambridge Cognition develops digital technology to deliver customer-focused solutions to assess brain health.

For 2020, the company reported a narrowed pretax loss of GBP649,000 from GBP3.1 million the year prior. Revenue increased 34% to GBP6.7 million from GBP5.0 million. Sales order intake was at GBP12.7 million, more than double the prior year's GBP4.9 million.

"The company delivered a strong performance in 2020, delivering on its growth strategy through focusing on commercialising its existing product range while continuing to invest in next generation products," the company said.

Cambridge Cognition does not pay dividends.

Chief Executive Matthew Stork said: "We have a strong pipeline of opportunities that we aim to convert into orders and revenues in 2021 to add to the GBP6.0 million of contracted order backlog we expect to realise this year.

"We were pleased to be profitable in the last quarter of 2020 and would expect that to continue into 2021. We are anticipating further revenue growth and plan to continue careful financial management and targeted investment in research and development."

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Apr 2021 11:24

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

Read more
30 Mar 2021 16:03

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

Read more
30 Mar 2021 13:56

Cambridge Cognition wins fourth schizophrenia trial contract

(Sharecast News) - Cambridge Cognition has won a £1.3m contract as the cognitive assessment partner for a schizophrenia trial, it announced on Tuesday.

Read more
16 Mar 2021 15:53

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Jan 2021 13:45

Cambridge Cognition Sees "Significant" Revenue Growth During 2020

Cambridge Cognition Sees "Significant" Revenue Growth During 2020

Read more
21 Dec 2020 14:20

IN BRIEF: Cambridge Cognition Wins GBP700,000 Digital Health Contract

IN BRIEF: Cambridge Cognition Wins GBP700,000 Digital Health Contract

Read more
7 Oct 2020 18:20

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

Read more
22 Sep 2020 14:12

UK EARNINGS SUMMARY: IGas Swings Sharply To Loss As Revenue Halves

UK EARNINGS SUMMARY: IGas Swings Sharply To Loss As Revenue Halves

Read more
15 Sep 2020 15:53

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
14 Sep 2020 13:13

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Read more
1 Sep 2020 16:22

Cambridge Cognition wins £2m contract with pharma firm

(Sharecast News) - Brain health company Cambridge Cognition has won a £2m contract as the cognitive assessment partner for three late-phase clinical trials for a pharmaceutical company's lead drug candidate for patients with schizophrenia, it announced on Tuesday.

Read more
1 Sep 2020 11:57

Cambridge Cognition Secures GBP2 Million Deal For Schizophrenia Trials

Cambridge Cognition Secures GBP2 Million Deal For Schizophrenia Trials

Read more
27 Jul 2020 17:58

UK EXECUTIVE CHANGE SUMMARY: Provident Financial Taps Former MP James

UK EXECUTIVE CHANGE SUMMARY: Provident Financial Taps Former MP James

Read more
20 Jul 2020 15:53

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.